Journal
ATHEROSCLEROSIS
Volume 192, Issue 1, Pages 184-189Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2006.04.033
Keywords
arterial stiffness; isoflavone metabolite; blood pressure; overweight; postmenopausal women
Ask authors/readers for more resources
Objectives: Isoflavones reduce arterial stiffness, a predictor of cardiovascular events. Whether metabolites of isoflavones have similar bioactivity is unknown. The effect of supplemental trans-tetrahydrodaidzein (THD) a metabolite of daidzein on pulse wave velocity (PWV), a measure of arterial stiffness was tested in overweight men and postmenopausal women.; mean [S.D.]) participated Methods: 25 subjects, I I postmenopausal women, 14 men (age, 57 [7] years; body mass index, 30.3 [4.7] kg/m(2) in a double-blind, randomized, cross-over trial of THD versus placebo. Design: 2 weeks run-in followed by either THD I g daily or placebo, each intervention 5 weeks. Aorta-femoral artery PWV, blood pressure and plasma lipids were measured after run-in, THD and placebo. Results: PWV was significantly reduced (signifying diminished central arterial stiffness): medians (25th and 75th%), placebo 9.9 m/s (8.7, 11.1), THD 8.8 m/s (7.9, 10.9); RM ANOVA P = 0.023, with Tukey procedure P < 0.05. Systolic blood pressure was significantly reduced: means (S.D.), placebo 125.6 (14.7), THD 121.3 (12.2) mmHg; Tukey P < 0.05. Plasma cholesterol, triglyceride and LDL cholesterol did not differ significantly. Absorption of THD > 80% substantially exceeded that of parent isoflavones. Conclusion: A metabolite normally formed after consumption of isoflavones (formononetin, daidezein), taken orally, reduced blood pressure and central arterial stiffness indicating reduced cardiovascular risk. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available